Source:http://linkedlifedata.com/resource/pubmed/id/16332412
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-2-27
|
pubmed:abstractText |
This study was designed to evaluate the effect of recombinant human erythropoietin (rhEPO), insulin-like growth factor-1 (rhIGF-1) and epidermal growth factor (rhEGF) on ischemia-induced hair cell loss in an organotypic cochlea culture. The apical, middle and basal parts of the organs of Corti (newborn rat, postnatal days 3-5) were exposed to ischemia (3.5 h) in glucose-free artificial perilymph (pO2 10-20 mmHg) with or without growth factors. Controls were exposed to normoxia. Twenty-four hours after the onset of ischemia, the cultures were stained using tetramethyl rhodamine isothiocyanate (TRITC) phalloidin (hair cells), propidium iodide (membrane integrity) and apoptosis detection kit (DNA-fragmentation). Ischemia (3.5 h) induced a hair cell loss of 20 and 40% in the middle and basal cochlear parts, respectively, and an increase of the numbers of PI-stained and DNA-fragmented nuclei (controls 0-1, ischemia 4-7 nuclei/100 microm). The basal part was more affected than the apical one. rhEPO and rhIGF-1 significantly attenuated the ischemia-induced hair cell loss by reducing processes involved in apoptosis and necrosis. rhEPO has been in clinical use for more than a decade and found to be well tolerated. Therefore, rhEPO could be an effective drug for the prevention of hearing loss via a hair cell protective mechanism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0304-3940
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
396
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
86-90
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16332412-Animals,
pubmed-meshheading:16332412-Animals, Newborn,
pubmed-meshheading:16332412-Apoptosis,
pubmed-meshheading:16332412-Epidermal Growth Factor,
pubmed-meshheading:16332412-Erythropoietin,
pubmed-meshheading:16332412-Hair Cells, Auditory,
pubmed-meshheading:16332412-Humans,
pubmed-meshheading:16332412-Insulin-Like Growth Factor I,
pubmed-meshheading:16332412-Ischemia,
pubmed-meshheading:16332412-Necrosis,
pubmed-meshheading:16332412-Organ of Corti,
pubmed-meshheading:16332412-Rats,
pubmed-meshheading:16332412-Recombinant Proteins
|
pubmed:year |
2006
|
pubmed:articleTitle |
Recombinant human erythropoietin prevents ischemia-induced apoptosis and necrosis in explant cultures of the rat organ of Corti.
|
pubmed:affiliation |
Brain Research Institute, Academy of Medical Sciences, Odukha 5, 105064 Moscow, Russia.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|